Multiplex Diagnostics Zepto Life Technology is building a highly multiplexed pathogen panel using GMR technology to deliver rapid, culture-independent diagnostics. This positions the company to target healthcare providers and labs seeking comprehensive infectious disease testing with faster turnaround.

GMR Platform The proprietary GMR biosensor platform offers rapid, culture-free diagnostics and could be attractive to hospitals, reference labs, and CRO partners looking to expand their infectious disease testing capabilities and improve patient management.

CLIA Lab Capabilities With a CLIA-certified reference laboratory and ongoing launches like FungiFlex panels, there are clear sales opportunities for contract testing, assay validation, and CRO collaborations for diagnostics commercialization.

Strategic Partnerships Advisory board additions and outreach to industry experts (e.g., Dr. David S. Perlin) signal a focus on science-forward partnerships; this can be leveraged to secure co-development deals, pilot programs, and joint marketing with academic and clinical collaborators.

Growth and Expansion Recent product launches in fungal diagnostics and ongoing representation at industry events indicate momentum in product expansion and market adoption, creating openings for scalable distribution agreements, VARs, and direct sales to diagnostics labs and healthcare systems.